Physician profile
Perham Mafi
NPI 1730443540
$3,086.90
in general payments reported to CMS, 2019-2025
8 companies · $337 in 2025
The $337 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.97 · 2023: $1,390 · 2024: $1,345 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,719 · Food and Beverage: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,718.84 |
| Food and Beverage | $1,353.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,406.32 | 2023-2024 | |
| Mentor Worldwide LLC | $430.04 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Motiva USA, LLC | $111.20 | 2025 | |
| Revance Therapeutics, INC. | $46.72 | 2024 | Daxxify |
| Daiichi Sankyo INC. | $27.60 | 2024 | Enhertu |
| Vertex Pharmaceuticals Incorporated | $26.41 | 2025 | |
| Botanix Sb INC | $23.64 | 2025 | Sofdra |
| Regeneron Healthcare Solutions, INC. | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perham Mafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.